Διασυνοριακός μετατροπέας
NACE-BEL 2025 21209 → ισοδύναμο CAE Rev 4 (Portugal)
Η εθνική ταξινόμηση δραστηριοτήτων της Belgium (NACE-BEL 2025) μοιράζεται την 4ψήφια ραχοκοκαλιά της με το πρότυπο NACE Rev 2.1 της ΕΕ. Με βάση αυτό, εμφανίζουμε τις ισοδύναμες υποτάξεις CAE Rev 4 που χρησιμοποιούνται στη Portugal.
Κοινή γονική τάξη ΕΕ
21.20
Manufacture of pharmaceutical preparations
This class includes: - manufacture of medicaments: • antisera and other blood fractions • vaccines • diverse medicaments, including homeopathic preparations - manufacture of chemical contraceptive products for external use and hormonal contraceptive medicaments - manufacture of medical diagnostic preparations, including pregnancy tests - manufacture of radioactive in-vivo diagnostic substances - manufacture of cell and gene advance therapy medical products This class also includes: - manufacture of medical impregnated wadding, gauze, bandages, dressings, etc. - preparation of botanical products (grinding, grading, milling) for pharmaceutical use - manufacture of viral vector-based medicines or vaccines - manufacture of pharmaceutical preparations for veterinary medicines This class excludes: - manufacture of herb infusions (mint, vervain, chamomile, etc.), see 10.83 - manufacture of probiotics, see 21.10 - manufacture of dental fillings and dental cement, see 32.50 - manufacture of bone reconstruction cements, see 32.50 - manufacture of surgical drapes, see 32.50 - wholesale of pharmaceuticals, see 46.46 - retail sale of pharmaceuticals, see 47.73 - research and development for pharmaceuticals and other biotech products, see 72.10 - packaging of pharmaceuticals, see 82.92
21209
Manufacture of other pharmaceutical products
21201
Fabricação de medicamentos
Compreende a fabricação de medicamentos alopáticos, homeopáticos e outros medicamentos de origem natural, para medicina humana e veterinária.
21202
Fabricação de outras preparações e de artigos farmacêuticos
Compreende a fabricação de preparações farmacêuticas, com exceção dos medicamentos, tais como: soros imunizantes e vacinas, incluindo de vetor viral; contracetivos; reagentes destinados à determinação dos grupos ou dos fatores sanguíneos; preparações opacificantes para exames radiográficos; substâncias radioativas para diagnóstico ¿in-vivo¿; reagentes de diagnóstico para aplicação no paciente.
Σχετικά με αυτή τη μετατροπή
Η NACE-BEL 2025 είναι η ταξινόμηση δραστηριοτήτων που χρησιμοποιείται στη Belgium. Η CAE Rev 4 είναι το ισοδύναμο σύστημα στη Portugal. Και τα δύο είναι εθνικές υλοποιήσεις της NACE Rev 2.1 της ΕΕ, οπότε κάθε 5ψήφια υποτάξη σε ένα σύστημα μπορεί να εντοπιστεί πίσω σε μια κοινή 4ψήφια τάξη ΕΕ — και από εκεί, να προβληθεί στις υποτάξεις της άλλης χώρας.
Αυτή η σελίδα δημιουργείται για το ερώτημα «NACE-BEL 2025 21209 προς CAE Rev 4» και παραμένει συγχρονισμένη με τον μηνιαίο συγχρονισμό Market Intelligence.